Nokea
The patient is admitted to the unit with the diagnosis of rhabdomyolysis. The patient is started on intravenous (IV) fluids and IV mannitol. What action by the nurse is best?
- A. Assess the patient’s hearing.
- B. Assess the patient’s lungs.
- C. Decrease IV fluids once the diuretic has been administered.
- D. Give extra doses before giving radiological contrast agents.
Correct Answer: B
Rationale: The correct answer is B: Assess the patient's lungs. In rhabdomyolysis, muscle breakdown releases myoglobin which can cause kidney damage. Mannitol is given to prevent kidney damage by promoting diuresis. However, mannitol can also cause fluid overload and pulmonary edema. Therefore, assessing the patient's lungs is crucial to monitor for signs of fluid overload and prevent complications.
A: Assessing the patient's hearing is not directly related to the management of rhabdomyolysis and mannitol administration.
C: Decreasing IV fluids after administering a diuretic like mannitol can lead to inadequate fluid resuscitation and worsening kidney injury.
D: Giving extra doses before radiological contrast agents is not necessary in the context of rhabdomyolysis and mannitol administration.
You may also like to solve these questions
Continuous venovenous hemodialysis is used to
- A. remove fluids and solutes through the process of convection.
- B. remove plasma water in cases of volume overload.
- C. remove plasma water and solutes by adding dialysate.
- D. combine ultrafiltration, convection and dialysis Continuous venovenous hemodialysis (CVVHD) is similar to CVVH in that ultrafiltration removes plasma water. It differs in that dialysate solution is added around the hemofilter membranes to facilitate solute removal by the process of diffusion. Continuous venovenous hemofiltration (CVVH) is used to remove fluids and solutes through the process of convection. Slow continuous ultrafiltration (SCUF) is also known as isolated ultrafiltration and is used to remove plasma water in cases of volume overload. Continuous venovenous hemodiafiltration (CVVHDF) combines ultrafiltration, convection, and dialysis to maximize fluid and solute removal.
Correct Answer: D
Rationale: The correct answer is D because continuous venovenous hemodiafiltration (CVVHDF) combines ultrafiltration, convection, and dialysis to maximize fluid and solute removal. Ultrafiltration removes plasma water, convection removes fluids and solutes, and dialysis facilitates solute removal through diffusion.
Choice A is incorrect because convection alone does not remove solutes, but CVVHDF combines convection with other methods.
Choice B is incorrect because CVVHDF is not specifically used for volume overload, although it does remove fluids.
Choice C is incorrect because CVVHDF does not involve adding dialysate to remove solutes; instead, it relies on diffusion for solute removal.
In summary, the correct answer D is the best choice as it encompasses all the components needed for comprehensive fluid and solute removal in CVVHDF.
Continuous renal replacement therapy (CRRT) differs from conventional intermittent hemodialysis in that
- A. a hemofilter is used to facilitate ultrafiltration.
- B. it provides faster removal of solute and water.
- C. it does not allow diffusion to occur.
- D. the process removes solutes and water slowly.
Correct Answer: D
Rationale: Step-by-step rationale:
1. CRRT removes solutes and water slowly to avoid hemodynamic instability.
2. Slow removal better tolerates fluid and electrolyte shifts in critically ill patients.
3. Unlike intermittent hemodialysis, CRRT provides continuous, gentle therapy.
4. Choice A is incorrect as both CRRT and intermittent hemodialysis use a hemofilter.
5. Choice B is incorrect as CRRT does not provide faster solute and water removal.
6. Choice C is incorrect as CRRT allows for diffusion to occur, albeit at a slower rate.
Summary:
Continuous renal replacement therapy (CRRT) removes solutes and water slowly to prevent hemodynamic instability, making it a gentler and more continuous process compared to intermittent hemodialysis. The other choices are incorrect as CRRT does use a hemofilter, does not provide faster removal, and still allows for diffusion to occur.
A patient with pancreatic cancer has been admitted to the critical care unit with clinical signs consistent with syndrome of inappropriate secretion of antidiuretic hormone. The nurse anticipates that clinical management of this condition will include
- A. administration of 3% normal saline.
- B. administration of exogenous vasopressin.
- C. fluid restriction.
- D. low sodium diet.
Correct Answer: C
Rationale: Step 1: Syndrome of inappropriate antidiuretic hormone (SIADH) leads to excess water retention, diluting sodium levels in the blood.
Step 2: Fluid restriction is the mainstay of treatment to prevent further dilution of sodium.
Step 3: Administering 3% normal saline (choice A) can worsen the condition by further increasing sodium levels.
Step 4: Exogenous vasopressin (choice B) would exacerbate the problem by increasing water retention.
Step 5: Low sodium diet (choice D) may be beneficial in the long term but is not the immediate priority.
The nurse is assessing a patient with a new arteriovenous fistula, but does not hear a bruit or feel a thrill. Pulses distal to the fistula are not palpable. The nurse should
- A. reassess the patient in an hour.
- B. raise the arm above the level of the patient’s heart.
- C. notify the provider immediately.
- D. apply warm packs to the fistula site and reassess.
Correct Answer: C
Rationale: The correct answer is C: notify the provider immediately. Lack of bruit, thrill, and distal pulse indicates potential complications like thrombosis or occlusion in the arteriovenous fistula. Prompt provider notification is crucial for timely intervention to prevent further complications such as ischemia or access failure. Reassessing the patient in an hour (A) may delay necessary intervention. Raising the arm above the level of the patient's heart (B) does not address the underlying issue. Applying warm packs (D) could worsen the situation if there is a clot present.
Which of the following statements is true about the medical management of diabetic ketoacidosis?
- A. Serum lactate levels are used to guide insulin administration.
- B. Sodium bicarbonate is a first-line medication for treatment.
- C. The degree of acidosis is assessed through continuous pulse oximetry.
- D. Volume replacement and insulin infusion often correct the acidosis.
Correct Answer: D
Rationale: The correct answer is D. Volume replacement and insulin infusion often correct the acidosis in diabetic ketoacidosis (DKA) because volume depletion and insulin deficiency are key factors in its pathophysiology. Volume replacement helps correct dehydration and improve tissue perfusion, while insulin infusion helps lower blood glucose levels and inhibit ketone production, ultimately correcting the acidosis.
A is incorrect because serum lactate levels are not typically used to guide insulin administration in DKA. B is incorrect as sodium bicarbonate is not a first-line medication for DKA treatment as it can worsen metabolic acidosis. C is incorrect as the degree of acidosis in DKA is typically assessed through blood gas analysis, not continuous pulse oximetry.